Some cancer drivers displayed both decreased accessibility and decreased mRNA levels, e.g., Brca1, E2f7 and Myh11 (Supplementary Figure S6), while others displayed increased accessibility and associated mRNA upregulation, e.g., Msi2, Bace2 (Supplementary Figure S7). Here, MYH11 is linked to cancer.